We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Aspirin Acts on Blood Vessels to Prevent Heart Attacks

By Biotechdaily staff writers
Posted on 24 Jun 2002
Researchers have found that the anti-inflammatory properties of aspirin help prevent heart disease by maintaining the flexibility of blood vessels. More...
This activity is in addition to aspirin's blood thinning ability. The report was published May 13, 2002, in the online edition of Circulation.

"Aspirin is widely used to prevent heart attacks and strokes, but it is assumed that its effects are solely attributable to its blood-thinning actions. But our research turns the clock back on aspirin, and suggests that some of aspirin's effects really are due to its anti-inflammatory properties, which people have known about for 100 years or more,” says Dr. Patrick J. T. Vallance, professor of clinical pharmacology at University College (London, UK; www.ucl.ac.uk).

Investigators used a typhoid vaccine to cause inflammation in 17 healthy volunteers to determine if aspirin would prevent changes to blood vessel function. Twelve of these people received either 1.2 g of aspirin or a placebo two hours before vaccination. The remaining five patients received aspirin after the vaccination.
Interluekin-1 (IL-1) levels were measured to monitor the level of inflammation. In the placebo group, IL-1 peaked at three hours and remained elevated until eight hours after vaccination. This corresponded to a 30-fold increase in baseline values. In the group treated with a single oral dose of aspirin before the vaccine, the concentration of IL-1 did not differ from baseline.

Next, the researchers measured endothelial function by infusing drugs that affect the endothelium into the artery of one arm and then measuring blood flow. The six participants who received a placebo had decreased forearm blood flow eight hours after vaccination compared to baseline, indicating a temporary stiffening of their blood vessels. However, the six who received aspirin showed an increase in forearm blood flow eight hours after vaccination, indicating a protective effect from aspirin.

Dr. Vallance summarized the research by saying, "There is an exciting opportunity to rethink how we use aspirin and whether there are situations in which we should be giving aspirin to reduce cardiovascular risk.”




Related Links:
University College London

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.